Roth MKM lowered the firm’s price target on Emeren (SOL) to $2 from $3 and keeps a Buy rating on the shares following a Q4 miss and “weak” 2025 outlook. The firm remains cautious as project pushouts continue to be a risk and needs to see consistent execution in order to have confidence that the stock can trade closer to the company’s net asset value of $5.90 per share, says the analyst, who cites valuation for the firm’s continued Buy rating.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOL: